Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jan;33(1):149–153. doi: 10.1128/jcm.33.1.149-153.1995

PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.

V A Steingrube 1, J L Gibson 1, B A Brown 1, Y Zhang 1, R W Wilson 1, M Rajagopalan 1, R J Wallace Jr 1
PMCID: PMC227898  PMID: 7699032

Abstract

A total of 129 reference and clinical strains of rapidly growing mycobacteria (RGM) belonging to 10 taxonomic groups were studied for restriction fragment length polymorphism patterns from a PCR-amplified 439-bp segment of the 65-kDa heat shock protein (HSP) gene. Of 24 endonucleases evaluated, restriction fragment length polymorphism patterns produced by HaeIII and BstEII and then by AciI and CfoI gave the best separation. Sixty percent of all RGM taxa studied were differentiated by HaeIII digests alone. Single unique patterns were observed with HaeIII and/or BstEII for Mycobacterium fortuitum (100%), M. chelonae (94%), M. abscessus (96%), M. smegmatis (100%), M. mucogenicum (formerly the M. chelonae-like organism) (100%), and the sorbitol-negative third biovariant of M. fortuitum (100%). Evidence is presented in support of two subgroups within M. peregrinum, M. smegmatis, and the unnamed third biovariant of M. fortuitum (sorbitol positive and sorbitol negative). PCR-based technology provides a rapid, accurate system for the identification of clinically important species of RGM which should be particularly useful for reference laboratories.

Full Text

The Full Text of this article is available as a PDF (436.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Band J. D., Ward J. I., Fraser D. W., Peterson N. J., Silcox V. A., Good R. C., Ostroy P. R., Kennedy J. Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis. 1982 Jan;145(1):9–17. doi: 10.1093/infdis/145.1.9. [DOI] [PubMed] [Google Scholar]
  2. Bolan G., Reingold A. L., Carson L. A., Silcox V. A., Woodley C. L., Hayes P. S., Hightower A. W., McFarland L., Brown J. W., 3rd, Petersen N. J. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis. 1985 Nov;152(5):1013–1019. doi: 10.1093/infdis/152.5.1013. [DOI] [PubMed] [Google Scholar]
  3. Cook S. M., Bartos R. E., Pierson C. L., Frank T. S. Detection and characterization of atypical mycobacteria by the polymerase chain reaction. Diagn Mol Pathol. 1994 Mar;3(1):53–58. doi: 10.1097/00019606-199403010-00009. [DOI] [PubMed] [Google Scholar]
  4. Griffith D. E., Girard W. M., Wallace R. J., Jr Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis. 1993 May;147(5):1271–1278. doi: 10.1164/ajrccm/147.5.1271. [DOI] [PubMed] [Google Scholar]
  5. Inyaku K., Hiyama K., Ishioka S., Inamizu T., Yamakido M. Rapid detection and identification of mycobacteria in sputum samples by nested polymerase chain reaction and restriction fragment length polymorphisms of dnaJ heat shock protein gene. Hiroshima J Med Sci. 1993 Mar;42(1):21–31. [PubMed] [Google Scholar]
  6. Kirschner P., Kiekenbeck M., Meissner D., Wolters J., Böttger E. C. Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification. J Clin Microbiol. 1992 Nov;30(11):2772–2775. doi: 10.1128/jcm.30.11.2772-2775.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lungu O., Della Latta P., Weitzman I., Silverstein S. Differentiation of Nocardia from rapidly growing Mycobacterium species by PCR-RFLP analysis. Diagn Microbiol Infect Dis. 1994 Jan;18(1):13–18. doi: 10.1016/0732-8893(94)90128-7. [DOI] [PubMed] [Google Scholar]
  8. Plikaytis B. B., Plikaytis B. D., Yakrus M. A., Butler W. R., Woodley C. L., Silcox V. A., Shinnick T. M. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol. 1992 Jul;30(7):1815–1822. doi: 10.1128/jcm.30.7.1815-1822.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Silcox V. A., Good R. C., Floyd M. M. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981 Dec;14(6):686–691. doi: 10.1128/jcm.14.6.686-691.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Steele L. C., Wallace R. J., Jr Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae. J Clin Microbiol. 1987 Feb;25(2):456–457. doi: 10.1128/jcm.25.2.456-457.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Telenti A., Marchesi F., Balz M., Bally F., Böttger E. C., Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993 Feb;31(2):175–178. doi: 10.1128/jcm.31.2.175-178.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Vaneechoutte M., De Beenhouwer H., Claeys G., Verschraegen G., De Rouck A., Paepe N., Elaichouni A., Portaels F. Identification of Mycobacterium species by using amplified ribosomal DNA restriction analysis. J Clin Microbiol. 1993 Aug;31(8):2061–2065. doi: 10.1128/jcm.31.8.2061-2065.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wallace R. J., Jr, Brown B. A., Silcox V. A., Tsukamura M., Nash D. R., Steele L. C., Steingrube V. A., Smith J., Sumter G., Zhang Y. S. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J Infect Dis. 1991 Mar;163(3):598–603. doi: 10.1093/infdis/163.3.598. [DOI] [PubMed] [Google Scholar]
  14. Wallace R. J., Jr, Nash D. R., Tsukamura M., Blacklock Z. M., Silcox V. A. Human disease due to Mycobacterium smegmatis. J Infect Dis. 1988 Jul;158(1):52–59. doi: 10.1093/infdis/158.1.52. [DOI] [PubMed] [Google Scholar]
  15. Wallace R. J., Jr, Silcox V. A., Tsukamura M., Brown B. A., Kilburn J. O., Butler W. R., Onyi G. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol. 1993 Dec;31(12):3231–3239. doi: 10.1128/jcm.31.12.3231-3239.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wallace R. J., Jr, Swenson J. M., Silcox V. A., Good R. C., Tschen J. A., Stone M. S. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983 Jul-Aug;5(4):657–679. doi: 10.1093/clinids/5.4.657. [DOI] [PubMed] [Google Scholar]
  17. Zhang Y., Wallace R. J., Jr, Steingrube V. A., Brown B. A., Nash R., Silcox A., Tsukamura M. Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria. Tuber Lung Dis. 1992 Dec;73(6):337–344. doi: 10.1016/0962-8479(92)90037-k. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES